mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0005 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |